Lexeo Therapeutics (LXEO) Earnings Date & Reports

Lexeo Therapeutics Inc is a clinical-stage genetic medicine company engaged in the development of gene therapy candidates targeting the underlying genetic causes of cardiovascular diseases... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

LXEO is expected to report earnings to rise 204.00% to -75 cents per share on August 19

Lexeo Therapeutics LXEO Stock Earnings Reports

Q2'26

Est.

$-0.76

Q1'26

Beat

by $0.49

Q4'25

Beat

by $0.59

Q3'25

Beat

by $0.51

Q2'25

Beat

by $0.31

The last earnings report on May 11 showed earnings per share of -25 cents, beating the estimate of -74 cents. With 393.87K shares outstanding, the current market capitalization sits at 395.75M.

View a ticker or compare two or three

Compare

LXEO

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for LXEO